THE RISK OF LATE BREAST CANCER SCREENING VERSUS AXILLARY LYMPHADENOPATHY ASSOCIATED WITH COVID-19 VACCINATION

THE RISK OF LATE BREAST CANCER SCREENING VERSUS AXILLARY LYMPHADENOPATHY ASSOCIATED WITH COVID-19 VACCINATION

Compartilhe


THE RISK OF LATE BREAST CANCER SCREENING VERSUS AXILLARY LYMPHADENOPATHY ASSOCIATED WITH COVID-19 VACCINATION (02)





The coronavirus disease 2019 (COVID-19) pandemic has significantly impacted morbidity and mortality worldwide. Unilateral axillary lymphadenopathy induced by the COVID-19 vaccine is particularly relevant in women with breast cancer, with a predilection for metastasis to the axillary lymph nodes. Clinicians, radiologists, and patients may be concerned about COVID-19 vaccine-induced unilateral axillary lymphadenopathy because it may be a sign of breast cancer metastasis, leading to a diagnostic conundrum over whether to recommend a biopsy or short-term follow-up. This literature review aims to assess the best available evidence of axillary lymphadenopathy after COVID-19 vaccination. Recognizing COVID-19 vaccine-induced unilateral axillary lymphadenopathy as a potential differential diagnosis and making efforts to investigate the patient's vaccination history are crucial to avoid overestimating the burden of axillary disease and making appropriate therapeutic recommendations.

Educação

Edições (1)

ver mais
THE RISK OF LATE BREAST CANCER SCREENING VERSUS AXILLARY LYMPHADENOPATHY ASSOCIATED WITH COVID-19 VACCINATION

Similares


Estatísticas

Desejam
Informações não disponíveis
Trocam
Informações não disponíveis
Avaliações 0 / 0
5
ranking 0
0%
4
ranking 0
0%
3
ranking 0
0%
2
ranking 0
0%
1
ranking 0
0%

0%

0%

Atena Editora
cadastrou em:
09/05/2022 13:44:27
Atena Editora
editou em:
09/05/2022 13:44:51

Utilizamos cookies e tecnologia para aprimorar sua experiência de navegação de acordo com a Política de Privacidade. ACEITAR